Chorionic Gonadotropin Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theChorionic Gonadotropin Market from 2025 to 2034?
The ever-growing instances of infertility problems are anticipated to amplify the development of the chorionic gonadotropin market. This term refers to the incapability to conceive a child after trying continuously for a year without any contraceptive measures for couples below 35 years or after six months for couples of 35 years of age or older. The reason behind rising infertility issues is primarily due to postponement of childbearing, as most individuals prefer to have children at later stages of their lives, along with lifestyle factors like obesity and smoking, that can severely affect reproductive health. Chorionic Gonadotropin (hCG) is applied in fertility treatments to stimulate ovulation in women, sustain the luteal phase for maintaining pregnancy, and boost testosterone production in men to increase sperm count, hence dealing with various infertility issues. As per the data of April 2023 from the World Health Organization (WHO), a Switzerland-based specialized agency, about 17.5% of the adult population or 1 in 6 individuals worldwide suffer from infertility, stressing the immediate necessity to enhance the availability of affordable, high-quality fertility care for the affected populace. Hence, the ever-increasing prevalence of infertility issues is enhancing the growth of the chorionic gonadotropin market. The anticipated development of the chorionic gonadotropin market can be attributed to the rise of assisted reproductive technologies. These medical procedures are used to aid individuals or couples to achieve pregnancy when they cannot do so naturally. The increase in assisted reproductive technologies (ART) is due to escalating infertility rates, advancements in medical science, postponed childbearing, and easy accessibility of ART procedures. Chorionic gonadotropin (hCG) has a crucial role in these procedures to instigate ovulation and support the luteal phase post embryo transfer to guarantee successful fertilization and early pregnancy. As per MJH Life Sciences, a US-based firm offering trusted health care professionals with reliable information, in April 2024, the number of performed ART cycles saw an upward trend with egg freezing cycles surging from 24,560 in 2021 to 29,803 in 2022. Thus, the amplified usage of assisted reproductive technologies is fuelling the growth of the chorionic gonadotropin market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp
#What is the Projected CAGR for the Chorionic Gonadotropin Market Size from 2025 to 2034?
The Chorionic Gonadotropin market has seen consistent growth, increasing from $1,260 million in 2024 to $1,340 million in 2025, reflecting a CAGR of 4.4%. Historical growth came from increased hCG awareness, treatment of hormonal disorders, affordability improvements, and assisted reproduction demand.
The chorionic gonadotropin market will grow steadily to $1,710 million in 2029 at a CAGR of 4%. Growth comes from infertility prevalence, reproductive health awareness, increased use of ART, hypogonadism in aging populations, and healthcare infrastructure improvement. Trends include recombinant tech progress, ART expansion, R&D investment, and new drug delivery formats.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19888
How Are Market Trends and Innovations Revolutionizing theChorionic Gonadotropin Industry in Recent Times?
The chorionic gonadotropin market’s primary trend is centred upon the development of pioneering solutions such as saliva-based pregnancy tests to enhance convenience, accuracy, and simplicity of access. The saliva-based pregnancy test is a non-invasive testing method that determines pregnancy by assessing the presence of human chorionic gonadotropin (hCG), a hormone found when pregnant, in a woman’s saliva. For example, in June 2023, Salignostics, a biotechnology firm based in Israel, made global headlines by launching the first-ever saliva-based pregnancy test. This groundbreaking product facilitates determination of pregnancy through the use of a saliva sample rather than a urine sample, detecting the hCG hormone and yielding results in just 5 to 15 minutes. Salistick provides a more user-friendly and handy testing experience, permitting users to conduct tests anywhere and share the results with their partners or family members.
Which Key Market Players Are Shaping the Future and Growth of theChorionic Gonadotropin Market?
Major companies operating in the chorionic gonadotropin market include Ferring Pharmaceuticals
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report
What Are the Core Segments of the Chorionic Gonadotropin Market, and How Do They Contribute to Growth?
The chorionic gonadotropinmarket covered in this report is segmented –
1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
4) By End User: Research Institutions; Pharmaceutical Companies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=19888&type=smp
What Regions Are Dominating the Chorionic Gonadotropin Market Growth?
North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Chorionic Gonadotropin Market 2025, By The Business Research Company:
Rheumatoid Arthritis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Arthritis Monoclonal Antibodies Global Market Report 2025
Global Biosimilar Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
